Pharmacokinetics of Vandetanib in Subjects with Renal or Hepatic Impairment

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.49, Iss.9, 2010-09, pp. : 607-618

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Asenapine Pharmacokinetics in Hepatic and Renal Impairment

By Peeters Pierre

Clinical Pharmacokinetics, Vol. 50, Iss. 7, 2011-07 ,pp. : 471-481

Adis International

Access to resources Recommend Favorite

Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Saxagliptin

By Boulton David W. Li Li Frevert Ernst U. Tang Angela Castaneda Lorna Vachharajani Nimish N. Kornhauser David M. Patel Chirag G.

Clinical Pharmacokinetics, Vol. 50, Iss. 4, 2011-04 ,pp. : 253-265

Adis International

Access to resources Recommend Favorite

Effects of Hepatic or Renal Impairment on the Pharmacokinetics of Aripiprazole

By Mallikaarjun Suresh

Clinical Pharmacokinetics, Vol. 47, Iss. 8, 2008-01 ,pp. : 533-542

Adis International

Access to resources Recommend Favorite

Effect of hepatic or renal impairment on the pharmacokinetics of casopitant, a NK-1 receptor antagonist

By Bauman John

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 662-671

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetics and Dosing Recommendations of Tenofovir Disoproxil Fumarate in Hepatic or Renal Impairment

By Kearney Brian P. Yale Kitty Shah Jaymin Zhong Lijie Flaherty John F.

Clinical Pharmacokinetics, Vol. 45, Iss. 11, 2006-01 ,pp. : 1115-1124

Adis International

Access to resources Recommend Favorite